Headline
The latest stories from AHA Today.
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi.
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual report.
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
A study published April 17 by JAMA Otolaryngology Head and Neck Surgery found that up to 32% of dementia cases from 2011-2019 could be attributed to hearing loss confirmed through testing.
The Centers for Disease Control and Prevention April 18 announced there have been 800 reported cases of measles across the country this year.
The Cybersecurity and Infrastructure Security Agency April 16 released guidance to reduce risks associated with a reported breach of Oracle cloud services.
A study published April 14 by JAMA Network Open found that rates of pancreatic and colon cancer rose among young adults from 2000-2021. Researchers examined 275,273 cases of pancreatic cancer and 215,200 cases of colon cancer during that period.
A Q&A in the latest edition of AHA Trustee Insights highlights how boards value the perspective of nurses. Experts interviewed include Kimberly Cleveland, board chair emeritus of the Nurses on Boards Coalition, Ann Collins, M.D., board chair of UNC Health Rex in Raleigh, N.C., and Melissa…
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements.
The AHA April 16 responded to the Lown Institute's latest report on hospital community benefits.